Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Journal of Diabetes in Developing Countries
Published in: International Journal of Diabetes in Developing Countries 3/2019

01-07-2019 | Obesity | Review Article

Importance of the Madras Diabetes Research Foundation-Indian Diabetes Risk Score (MDRF-IDRS) for mass screening of type 2 diabetes and its complications at primary health care centers of North India

Authors: Mohammad Mustufa Khan, Gyanendra Kumar Sonkar, Sangeeta Singh, Satyendra Kumar Sonkar

Published in: International Journal of Diabetes in Developing Countries | Issue 3/2019

Login to get access

Abstract

Diabetes in combination with abdominal obesity and hypertension is the leading cause of cardiovascular diseases (CVD) and death. Type 2 diabetes (T2DM) increases CVD risk in two- to fourfold. The prevalence of CVD is constantly rising in India and is higher in urban areas. In addition, more than 50% of diabetic patients are still undiagnosed in the general population. The Madras Diabetes Research Foundation-Indian Diabetes Risk Score (MDRF-IDRS) is a cost-effective and very simple tool, which can be used at a primary health care center routinely. It is observed that people with increasing age, sedentary lifestyle, greater abdominal obesity, and family history of diabetes are at a high risk for diabetes and its complications. MDRF-IDRS is helpful for mass screening of diabetes and its complications in North Indian population to prevent the incidence of diabetes and with lifestyle interventions, knowledge, and awareness, it helps to reduce and revert the complications of diabetes. It is suggested that regular practice of MDRF-IDRS-based screening at primary health care center may also reduce the burden at the critical care center in North India.
Literature
1.
IDF: International Diabetes Federation. IDF Diabetes Atlas. 7th ed. Brussels, Belgium: International Diabetes Federation; 2015.
2.
3.
Joshi SR, Das AK, Vijay VJ, Mohan V. Challenges in diabetes care in India: sheer numbers, lack of awareness and inadequate control. J Assoc Physicians India. 2008;56:443–50.PubMed
4.
Mohan V, Sandeep S, Deepa M, Gokulakrishnan K, Datta M, Deepa R. A diabetes risk score helps identify metabolic syndrome and cardiovascular risk in Indians-the Chennai Urban Rural Epidemiology Study (CURES-38). Diabetes Obes Metab. 2007;9:337–43.CrossRefPubMed
5.
Raoa M, Xavier D, Devi P, Sigamani A, Faruqui A, Gupta R, et al. Prevalence, treatments and outcomes of coronary artery disease in Indians: a systematic review. Indian Heart J. 2015;67:302–10.CrossRef
6.
Mohan V, Deepa R, Rani SS, Premalatha G. Prevalence of coronary artery disease and its relationship to lipids in a selected population in South India. The Chennai Urban Population Study (CUPS No. 5). J Am Coll Cardiol. 2001;38(3):682–7.CrossRefPubMed
7.
8.
9.
10.
Mohan V, Deepa R, Deepa M, Somannavar S, Datta M. A simplified Indian diabetes risk score for screening for undiagnosed diabetic subjects. J Assoc Physicians India. 2005;53:759–63.PubMed
11.
Mohan V, Mathur P, Deepa R, Deepa M, Shukla DK, Menon GR, et al. Urban rural differences in prevalence of self-reported diabetes in India – the WHO-ICMR Indian NCD risk factor surveillance. Diabetes Res Clin Pract. 2008;80:159–68.CrossRefPubMed
12.
Gupta SK, Singh Z, Purty AJ, Vishwanathan M. Diabetes prevalence and its risk factors in urban Pondicherry. Int J Diabetes Dev Ctries. 2009;29:166–9.CrossRefPubMedPubMedCentral
13.
Gupta SK, Singh Z, Purty AJ, Kar M, Vedapriya D, Mahajan P, et al. Diabetes prevalence and its risk factors in rural area of Tamil Nadu. Indian J Community Med. 2010;35:396–9.CrossRefPubMedPubMedCentral
14.
Gore CA, Subramanian M. Diabetes risk in an urban slum population in Bangalore, India. Int J Prevent Public Health Sci. 2016;1(6):11–4.
15.
Patil RS, Gothankar JS. Assessment of risk of type 2 diabetes using the Indian diabetes risk score in an urban slum of Pune, Maharashtra, India: a cross-sectional study. WHO South-East Asia J Public Health. 2016;5(1):53–61.CrossRefPubMed
16.
Turale AD, Khandekar V, Patrikar VG. Indian diabetes risk score for screening of undiagnosed pre-diabetic individuals of Sakkardara region of Nagpur City. Int Ayurvedic Med J. 2017;5(10):3722–5.
17.
Agarwal AK, Ahirwar G, Marskole P, Bhagwat AK. A community based study to assess the validity of Indian diabetic risk score, among urban population of North Central India. Int J Community Med Public Health. 2017;4:2101–6.CrossRef
18.
Nanandeshwar S, Jamra V, Pal DK. Indian diabetic risk score for screening of undiagnosed diabetic subjects of Bhopal city. Natl J Community Med. 2010;1(2):176–7.
19.
Khan MM, Sonkar GK, Alam R, Mehrotra S, Khan MS, Kumar A, et al. Validity of Indian Diabetes Risk Score and its association with body mass index and glycosylated hemoglobin for screening of diabetes in and around areas of Lucknow. J Family Med Prim Care. 2017;6:366–73.CrossRefPubMedPubMedCentral
20.
Acharya AS, Singh A, Dhiman B. Assessment of diabetes risk in an adult population using Indian Diabetes Risk Score in an urban resettlement colony of Delhi. J Assoc Physicians India. 2017;65:46–51.PubMed
21.
22.
Kaushal K, Mahajan A, Parashar A, Dhadwal DS, Jaswal V, Jaret P, et al. Validity of madras diabetes research foundation: Indian diabetes risk score for screening of diabetes mellitus among adult population of urban field practice area, Indira Gandhi Medical College, Shimla, Himachal Pradesh, India. Indian J Endocr Metab. 2017;21:876–81.CrossRef
23.
Gupta RK, Shora TN, Verma AK, Raina SK. Utility of MDRF-IDRS (Madras Diabetes Research Foundation-Indian Diabetes Risk Score) as a tool to assess risk for diabetes—a study from north-west India. Int J Diabetes Dev Ctries. 2015;35(4):570–2.CrossRef
24.
Chowdhury R, Mukherjee A, Lahiri SK. A study on distribution and determinants of Indian Diabetic Risk Score (IDRS) among rural population of West Bengal. Natl J Med Res. 2012;2(3):282–6.
25.
Mohan V, Vassy JL, Pradeepa R, Deepa M, Subashini S. The Indian type 2 diabetes risk score also helps identify those at risk of macrovasvular disease and neuropathy (CURES-77). J Assoc Physicians India. 2010;58:430–3.PubMed
26.
Jain A, Paranjape S. Prevalence of type 2 diabetes mellitus in elderly in a primary care facility: an ideal facility. Indian J Endocrinol Metab. 2013;17(Suppl 1):S318–22.PubMedPubMedCentral
27.
Palta P, Huang ES, Kalyani RR, Golden SH, Yeh HC. Hemoglobin A1C and mortality in older adults with and without diabetes: results from the National Health and nutrition examination surveys (1988–2011). Diabetes Care. 2017;40:453–60.CrossRefPubMedPubMedCentral
28.
Kilkenny MF, Dunstan L, Busingye D, Purvis T, Reyneke M, Orgill M, et al. Knowledge of risk factors for diabetes or cardiovascular disease (CVD) is poor among individuals with risk factors for CVD. PLoS One. 2017;12(2):e0172941.CrossRefPubMedPubMedCentral
29.
Dhana K, Koolhaas CM, van Rossum EFC, Ikram MA, Hofman A, Kavousi M, et al. Metabolically healthy obesity and the risk of cardiovascular disease in the elderly population. PLoS One. 2016;11(4):e0154273.CrossRefPubMedPubMedCentral
30.
Srinivasan MP, Kamath PK, Bhat NM, Pai ND, Bhat RU, Shah TD, et al. Severity of coronary artery disease in type 2 diabetes mellitus: does the timing matter? Indian Heart J. 2016;68(2):158–63.CrossRefPubMedPubMedCentral
31.
Qi Q, Meigs JB, Rexrode KM, Hu FB, Qi L. Diabetes genetic predisposition score and cardiovascular complications among patients with type 2 diabetes. Diabetes Care. 2013;36(3):737–9.CrossRefPubMedPubMedCentral
32.
Bennet L, Lindblad U, Franks PW. A family history of diabetes determines poorer glycaemic control and younger age of diabetes onset in immigrants from the Middle East compared with native swedes. Diabetes Metab. 2015;41:45–54.CrossRefPubMed
33.
Park GM, Cho YR, Lee SW, Yun SC, Gil EH, Kim DW, et al. Family history of diabetes and the risk of subclinical atherosclerosis. Diabetes Metab. 2016;42(3):170–7.CrossRefPubMed
34.
Park JW, Yun JE, Park T, Cho E, Jee SH, Jang Y, et al. Family history of diabetes and risk of atherosclerotic cardiovascular disease in Korean men and women. Atherosclerosis. 2008;197:224–31.CrossRefPubMed
35.
Hariri S, Yoon PW, Qureshi N, Valdez R, Scheuner MT, Khoury MJ. Family history of type 2 diabetes: a population-based screening tool for prevention? Genet Med. 2006;8(2):102–8.CrossRefPubMed
36.
Zhao Y, Song C, Ma X, Ma X, Wang Q, Ji H, et al. Synergistic effect of family history of diabetes and dietary habits on the risk of type 2 diabetes in Central China. Int J Endocrinol. 2017:Article ID 9707284:8.
37.
Marinou K, Hodson L, Vasan SK, Fielding BA, Banerjee R, Brismar K, et al. Structural and functional properties of deep abdominal subcutaneous adipose tissue explain its association with insulin resistance and cardiovascular risk in men. Diabetes Care. 2014;37:821–9.CrossRefPubMed
38.
Anand SS, Tarnopolsky MA, Rashid S, Schulze KM, Desai D, Mente A, et al. Adipocyte hypertrophy, fatty liver and metabolic risk factors in south Asians: the molecular study of health and risk in ethnic groups (Mol-SHARE). PLoS One. 2011;6:e22112.CrossRefPubMedPubMedCentral
39.
Raji A, Seely EW, Arky RA, Simonson DC. Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians. J Clin Endocrinol Metab. 2001;86:5366–71.CrossRefPubMed
40.
Anoop S, Misra A, Mani K, Pandey RM, Gulati S, Bhatt SP, et al. Estimation of liver span using MRI for prediction of type 2 diabetes in non-obese Asian Indians. J Diabetes Sci Technol. 2017;11:446–7.CrossRefPubMedPubMedCentral
41.
Deepa M, Farooq S, Deepa R, Manjula D, Mohan V. Prevalence and significance of generalized and central body obesity in an urban Asian Indian population in Chennai, India (CURES: 47). Eur J Clin Nutr. 2009;63:259–67.CrossRefPubMed
42.
World Health Organization (WHO). The Asia Pacific perspective. Redefining obesity and its treatment. International Association for the Study of Obesity and International Obesity Task Force. Melbourne: International Diabetes Institute; 2000.
43.
World Health Organization (WHO) Expert Consultation. Appropriate body mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157–63.CrossRef
44.
Pradeepa R, Anjana RM, Joshi SR, Bhansali A, Deepa M, Joshi PP, et al. Prevalence of generalized and abdominal obesity in urban and rural India – the ICMR-INDIAB study (phase-I) [ICMR-NDIAB-3]. Indian J Med Res. 2015;142:139–50.CrossRefPubMedPubMedCentral
45.
Fan H, Li X, Zheng L, Chen X, Lan Q, Wu H, et al. Abdominal obesity is strongly associated with Cardiovascular disease and its risk factors in elderly and very elderly community-dwelling Chinese. Sci Repo. 2016;6:21521.CrossRef
46.
47.
Kim MK, Lee WY, Kang JH, Kang JH, Kim BT, Kim SM, et al. 2014 clinical practice guidelines for overweight and obesity in Korea. Endocrinol Metab (Seoul). 2014;29:405–9.CrossRef
48.
Aune D, Sen A, Norat T, Janszky I, Romundstad P, Tonstad S, et al. Body mass index, abdominal fatness, and heart failure incidence and mortality: a systematic review and dose-response meta-analysis of prospective studies. Circulation. 2016;133:639–49.CrossRefPubMed
49.
Gulati S, Misra A. Abdominal obesity and type 2 diabetes in Asian Indians: dietary strategies including edible oils, cooking practices and sugar intake. Eur J Clin Nutr. 2017;71:850–7.CrossRefPubMed
50.
Anjana RM, Pradeepa R, Das AK, Deepa M, Bhansali A, Joshi SR, et al. Physical activity and inactivity patterns in India – results from the ICMR-INDIAB study (Phase-1) [ICMR-INDIAB-5]. Int J Behav Nutr Phys Act. 2014;11:26.CrossRefPubMedPubMedCentral
51.
52.
53.
Tanasescu M, Leitzmann MF, Rimm EB, Hu FB. Physical activity in relation to cardiovascular disease and total mortality among men with type 2 diabetes. Circulation. 2003;107(19):2435–9.CrossRefPubMed
54.
Wahid A, Manek N, Nichols M, Kelly P, Foster C, Webster P, et al. Quantifying the association between physical activity and cardiovascular disease and diabetes: a systematic review and meta-analysis. J Am Heart Assoc. 2016;5(9):e002495.CrossRefPubMedPubMedCentral
55.
Deepa M, Anjana RM, Mohan V. Role of lifestyle factors in the epidemic of diabetes: lessons learnt from India. Eur J Clin Nutr. 2017;71:825–31.CrossRefPubMed
56.
57.
58.
59.
Caro JJ, Ward AJ, O’Brien JA. Lifetime costs of complications resulting from type 2 diabetes in the U.S. Diabetes Care. 2002;25:476–81.CrossRefPubMed
60.
O’Brien JA, Patrick AR, Caro J. Estimates of direct medical costs for microvascular and macrovascular complications resulting from type 2 diabetes mellitus in the United States in 2000. Clin Ther. 2003;25:1017–38.CrossRefPubMed
61.
Falciglia M, Freyberg RW, Almenoff PL, D’Alessio DA, Render ML. Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis. Crit Care Med. 2009;37(12):3001–9.CrossRefPubMedPubMedCentral
62.
Maniarasu K, Muthunarayanan L. Prevalence of certain chronic complications of diabetes among type 2 diabetic patients in rural population of Kancheepuram District, Tamil Nadu- a cross sectional study. Int J Med Public Health. 2017;7(1):41–6.CrossRef
63.
Mokta J, Mokta K, Ranjan A, Garg M. Prevalence of cardiovascular risk factors among diabetic population and awareness of diabetes among diabetic patients: a population based Himalayan study. J Assoc Physicians India. 2017;65(2):48–52.PubMed
64.
Tripathy JP, Thakur JS, Jeet G, Chawla S, Sanjay Jain S, Pal A, et al. Prevalence and risk factors of diabetes in a large community-based study in North India: results from a STEPS survey in Punjab, India. Diabetol Metab Syndr. 2017;9:8.CrossRefPubMedPubMedCentral
65.
66.
Decode study group; on behalf of the European Diabetes Epidemiology Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med. 2001;161(3):397–405.CrossRef
67.
Mohan V, Anbalagan VP. Expanding role of the madras diabetes research foundation – Indian diabetes risk score in clinical practice. Indian J Endocrinol Metab. 2013;17:31–6.CrossRefPubMedPubMedCentral
68.
69.
Sukla P, Shrivastava SRBL, Prateek Saurabh Shrivastava PS. A longitudinal study to assess the impact of exercise on clinical, biochemical, and anthropometric parameters among the type 2 diabetes patients of South India. Avicenna J Med. 2015;5(1):16–20.CrossRefPubMedPubMedCentral
70.
Cárdenas FG, Bawaked RA, Martínez GMÁ, Corella D, Subirana CI, Salas-Salvadó J, et al. Association of physical activity with body mass index, waist circumference and incidence of obesity in older adults. Eur J Pub Health. 2018;28(5):944–50.CrossRef
71.
72.
Stanford KI, Goodyear LJ. Exercise and type 2 diabetes: molecular mechanisms regulating glucose uptake in skeletal muscle. Adv Physiol Educ. 2014;38(4):308–14.CrossRefPubMedPubMedCentral
73.
Way KL, Hackett DA, Baker MK, Johnson NA. The effect of regular exercise on insulin sensitivity in type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetes Metab J. 2016;40:253–71.CrossRefPubMedPubMedCentral
74.
75.
Højbjerre L, Sonne MP, Alibegovic AC, Nielsen NB, Dela F, Vaag A, et al. Impact of physical inactivity on adipose tissue low-grade inflammation in first-degree relatives of type 2 diabetic patients. Diabetes Care. 2011;34:2265–72.CrossRefPubMedPubMedCentral
76.
Shapiro L, Scherer PE. The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor. Curr Biol. 1998;8:335–8.CrossRefPubMed
Metadata
Title
Importance of the Madras Diabetes Research Foundation-Indian Diabetes Risk Score (MDRF-IDRS) for mass screening of type 2 diabetes and its complications at primary health care centers of North India
Authors
Mohammad Mustufa Khan
Gyanendra Kumar Sonkar
Sangeeta Singh
Satyendra Kumar Sonkar
Publication date
01-07-2019
Publisher
Springer India
Published in
International Journal of Diabetes in Developing Countries / Issue 3/2019
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-018-0710-6

Other articles of this Issue 3/2019

International Journal of Diabetes in Developing Countries 3/2019 Go to the issue

Original Article

Therapeutic effect of catalpol on type 2 diabetic mice induced by STZ and high-fat diet and its possible mechanism

Editorial

The clinical relevance of lipohypertrophy

Original Article

Effect of whole-grain plant-based diet on the diabetes mellitus type 2 features in newly diagnosed patients: a pilot study

Original Article

Varied presentations and outcomes of Charcot neuroarthropathy in patients with diabetes mellitus

Original Article

Hand function in people with type 1 and type 2 diabetes

Original Article

Effect of prenatal zinc supplementation on adipose tissue-derived hormones and neonatal weight, height and head circumference in women with impaired glucose tolerance test: randomized clinical controlled trial
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits